Literature DB >> 6800399

A new systematic treatment for infertile women with abnormal hormone profiles.

R Fleming, A H Adam, D H Barlow, W P Black, M C MacNaughton, J R Coutts.   

Abstract

Five infertile women, with normal menstrual rhythm who had been investigated previously by daily hormone analyses throughout at least one complete menstrual cycle and had shown poor luteal-phase steroid-hormone profiles were treated by a new approach. They were rendered hypogonadotrophic with large doses of a luteinizing hormone releasing-hormone analogue (Hoe 766) and were then treated with exogenous gonadotrophins to induce follicular growth and ovulation. Progesterone production after ovulation in all cases was superior to that observed in the individual patients' without treatment. One patients conceived in her first conception cycle and another in her fourth. This regimen offers a systematic approach to the treatment of unexplained infertility in women with deficient luteal-phase steroid-hormone profiles.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6800399     DOI： 10.1111/j.1471-0528.1982.tb04642.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN： 0306-5456


  21 in total

Review 1.  Buserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical profile.

Authors:  R N Brogden; M M Buckley; A Ward
Journal:  Drugs       Date:  1990-03       Impact factor: 9.546

2.  The uses of LH-releasing hormone and analogs in infertility.

Authors:  R Fleming; C Conaghan; J R Coutts
Journal:  Ir J Med Sci       Date:  1986-12       Impact factor: 1.568

Review 3.  Progress in ovulation induction with gonadotropins.

Authors:  P R Gindoff; R Jewelewicz
Journal:  Bull N Y Acad Med       Date:  1989-06

4.  The duration of pituitary suppression by means of intranasal gonadotropin hormone-releasing hormone analogue administration does not influence the ovarian response to gonadotropin stimulation and success rate in a gamete intrafallopian transfer (GIFT) program.

Authors:  V Remorgida; P Anserini; S Croce; M Costa; A Ferraiolo; A Centonze; G Gaggero; G L Capitanio
Journal:  J In Vitro Fert Embryo Transf       Date:  1989-04

5.  Comparison of ovarian stimulation regimens for in vitro fertilization (IVE) with and without a gonadotropin-releasing hormone (GnRH) agonist: results of a randomized study.

Authors:  A B van de-Helder; F M Helmerhorst; A Blankhart; R Brand; C Waegemaekers; N Naaktgeboren
Journal:  J In Vitro Fert Embryo Transf       Date:  1990-12

6.  Comparison between a single dose of goserelin (depot) and multiple daily doses of leuprolide acetate for pituitary suppression in IVF treatment: a clinical endocrinological study of the ovarian response.

Authors:  Selmo Geber; Liana Sales; Marcos A C Sampaio
Journal:  J Assist Reprod Genet       Date:  2002-07       Impact factor: 3.412

7.  Pituitary down-regulation using leuprolide for the intensive ovulation management of poor prognosis patients having in vitro fertilization (IVF)-related treatments.

Authors:  J M Cummins; J M Yovich; W R Edirisinghe; J L Yovich
Journal:  J In Vitro Fert Embryo Transf       Date:  1989-12

8.  A comparative study of three ovulation induction protocols in polycystic ovarian disease patients in an in vitro fertilization/embryo transfer program.

Authors:  N O Turhan; P G Artini; G D'Ambrogio; F Droghini; C Battaglia; A D Genazzani; A Volpe; A R Genazzani
Journal:  J Assist Reprod Genet       Date:  1993-01       Impact factor: 3.412

Review 9.  GnRH agonists and antagonists. Current clinical status.

Authors:  M Filicori; C Flamigni
Journal:  Drugs       Date:  1988-01       Impact factor: 9.546

10.  A randomized prospective study on the effect of short and long buserelin treatment in women with repeated unsuccessful in vitro fertilization (IVF) cycles due to inadequate ovarian response.

Authors:  M Dirnfeld; Y Gonen; A Lissak; S Goldman; M Koifman; Y Sorokin; H Abramovici
Journal:  J In Vitro Fert Embryo Transf       Date:  1991-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.